Jon P Stonehouse - Net Worth and Insider Trading
Jon P Stonehouse Net Worth
The estimated net worth of Jon P Stonehouse is at least $9 Million dollars as of 2024-11-29. Jon P Stonehouse is the President & CEO of BioCryst Pharmaceuticals Inc and owns about 1,167,770 shares of BioCryst Pharmaceuticals Inc (BCRX) stock worth over $9 Million. Jon P Stonehouse is also the Director of Bellicum Pharmaceuticals Inc and owns about 1,000 shares of Bellicum Pharmaceuticals Inc (BLCM) stock worth over $75. Details can be seen in Jon P Stonehouse's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jon P Stonehouse has not made any transactions after 2024-05-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jon P Stonehouse
Jon P Stonehouse Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jon P Stonehouse owns 2 companies in total, including Bellicum Pharmaceuticals Inc (BLCM) , and BioCryst Pharmaceuticals Inc (BCRX) .
Click here to see the complete history of Jon P Stonehouse’s form 4 insider trades.
Insider Ownership Summary of Jon P Stonehouse
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BLCM | Bellicum Pharmaceuticals Inc | 2018-11-09 | director |
| BCRX | BioCryst Pharmaceuticals Inc | 2024-05-13 | director & CEO |
Jon P Stonehouse Latest Holdings Summary
Jon P Stonehouse currently owns a total of 2 stocks. Among these stocks, Jon P Stonehouse owns 1,167,770 shares of BioCryst Pharmaceuticals Inc (BCRX) as of May 13, 2024, with a value of $9 Million and a weighting of 100%. Jon P Stonehouse also owns 1,000 shares of Bellicum Pharmaceuticals Inc (BLCM) as of November 9, 2018, with a value of $75 and a weighting of 0%.
Latest Holdings of Jon P Stonehouse
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BCRX | BioCryst Pharmaceuticals Inc | 2024-05-13 | 1,167,770 | 7.50 | 8,758,275 |
| BLCM | Bellicum Pharmaceuticals Inc | 2018-11-09 | 1,000 | 0.07 | 75 |
Holding Weightings of Jon P Stonehouse
Jon P Stonehouse Form 4 Trading Tracker
According to the SEC Form 4 filings, Jon P Stonehouse has made a total of 6 transactions in BioCryst Pharmaceuticals Inc (BCRX) over the past 5 years, including 1 buys and 5 sells. The most-recent trade in BioCryst Pharmaceuticals Inc is the acquisition of 30,000 shares on May 13, 2024, which cost Jon P Stonehouse around $166,500.
According to the SEC Form 4 filings, Jon P Stonehouse has made a total of 0 transactions in Bellicum Pharmaceuticals Inc (BLCM) over the past 5 years. The most-recent trade in Bellicum Pharmaceuticals Inc is the acquisition of 1,000 shares on November 9, 2018, which cost Jon P Stonehouse around $45,600.
Insider Trading History of Jon P Stonehouse
- 1
Jon P Stonehouse Trading Performance
GuruFocus tracks the stock performance after each of Jon P Stonehouse's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jon P Stonehouse is 4.26%. GuruFocus also compares Jon P Stonehouse's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jon P Stonehouse within 3 months outperforms 7 times out of 13 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jon P Stonehouse's insider trading performs compared to the benchmark.
Performance of Jon P Stonehouse
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 8.66 | | | | | |
| Relative Return to S&P 500(%) | 9.31 | | | | | |
Jon P Stonehouse Ownership Network
Jon P Stonehouse Owned Company Details
What does Bellicum Pharmaceuticals Inc do?
Who are the key executives at Bellicum Pharmaceuticals Inc?
Jon P Stonehouse is the director of Bellicum Pharmaceuticals Inc. Other key executives at Bellicum Pharmaceuticals Inc include Chief Development Officer Charity Scripture , Principal Accounting Officer Charles S. Grass , and director & President and CEO Richard A. Fair .
Bellicum Pharmaceuticals Inc (BLCM) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Bellicum Pharmaceuticals Inc (BLCM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Bellicum Pharmaceuticals Inc (BLCM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Bellicum Pharmaceuticals Inc (BLCM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Bellicum Pharmaceuticals Inc Insider Transactions
Jon P Stonehouse Mailing Address
Above is the net worth, insider trading, and ownership report for Jon P Stonehouse. You might contact Jon P Stonehouse via mailing address: 2190 Parkway Lake Dr, Birmingham Al 35244.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
